These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23834205)

  • 1. Acid-citrate-dextrose Formula A versus heparin as primary catheter lock solutions for therapeutic apheresis.
    Osby M; Barton P; Lam CN; Tran MH
    Transfusion; 2014 Mar; 54(3):735-43. PubMed ID: 23834205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Citrate versus heparin for apheresis catheter locks: an efficacy analysis.
    Passero BA; Zappone P; Lee HE; Novak C; Maceira EL; Naber M
    J Clin Apher; 2015 Feb; 30(1):22-7. PubMed ID: 25132635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catheter outcomes in the short-term inpatient setting: a controlled quality improvement study comparing citrate and heparin lock.
    Parikh S; Nijmeh R; Van Cleef S; Timmerman S; Bhatt UY; Agarwal AK
    Semin Dial; 2012 May; 25(3):351-6. PubMed ID: 22074231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients.
    Moran J; Sun S; Khababa I; Pedan A; Doss S; Schiller B
    Am J Kidney Dis; 2012 Jan; 59(1):102-7. PubMed ID: 22088576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional citrate anticoagulation with calcium replacement in pediatric apheresis.
    Sigler K; Lee J; Srivaths P
    J Clin Apher; 2018 Jun; 33(3):274-277. PubMed ID: 29027706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exclusive use of acid citrate dextrose for anticoagulation during extracorporeal photopheresis in patients with contraindications to heparin: an effective protocol.
    Nedelcu E; Ziman A; Fernando LP; Cook K; Bumerts P; Schiller G
    J Clin Apher; 2008; 23(2):66-73. PubMed ID: 18286495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of systemic delivery of substrates for intermediate metabolism during citrate anticoagulation of continuous renal replacement therapy.
    Balik M; Zakharchenko M; Otahal M; Hruby J; Polak F; Rusinova K; Stach Z; Vavrova J; Jabor A
    Blood Purif; 2012; 33(1-3):80-7. PubMed ID: 22212643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial.
    Power A; Duncan N; Singh SK; Brown W; Dalby E; Edwards C; Lynch K; Prout V; Cairns T; Griffith M; McLean A; Palmer A; Taube D
    Am J Kidney Dis; 2009 Jun; 53(6):1034-41. PubMed ID: 19394731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized controlled trial of taurolidine citrate versus heparin as catheter lock solution in paediatric patients with haematological malignancies.
    Dümichen MJ; Seeger K; Lode HN; Kühl JS; Ebell W; Degenhardt P; Singer M; Geffers C; Querfeld U
    J Hosp Infect; 2012 Apr; 80(4):304-9. PubMed ID: 22342714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional anticoagulation with acid citrate dextrose-A for extracorporeal photoimmunochemotherapy.
    Apsner R; Uenver B; Sunder-Plassmann G; Knobler RM
    Vox Sang; 2002 Oct; 83(3):222-6. PubMed ID: 12366763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin versus citrate regional anticoagulation during autotransfusion in a porcine intra-abdominal hemorrhage model.
    Howdieshell TR; Gay M; DiPiro JT; Mooney S; Duvall R; Eckles S; Baisden R
    Am Surg; 1997 Nov; 63(11):1014-8. PubMed ID: 9358794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation techniques in apheresis: from heparin to citrate and beyond.
    Lee G; Arepally GM
    J Clin Apher; 2012; 27(3):117-25. PubMed ID: 22532037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium citrate 4% locking solution for central venous dialysis catheters--an effective, more cost-efficient alternative to heparin.
    Grudzinski L; Quinan P; Kwok S; Pierratos A
    Nephrol Dial Transplant; 2007 Feb; 22(2):471-6. PubMed ID: 17065193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: a multi-center, controlled, randomized trial.
    Maki DG; Ash SR; Winger RK; Lavin P;
    Crit Care Med; 2011 Apr; 39(4):613-20. PubMed ID: 21200319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution.
    Betjes MG; van Agteren M
    Nephrol Dial Transplant; 2004 Jun; 19(6):1546-51. PubMed ID: 14993498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Citrate versus unfractionated heparin for anticoagulation in continuous renal replacement therapy.
    Liao YJ; Zhang L; Zeng XX; Fu P
    Chin Med J (Engl); 2013 Apr; 126(7):1344-9. PubMed ID: 23557569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis.
    Solomon LR; Cheesbrough JS; Ebah L; Al-Sayed T; Heap M; Millband N; Waterhouse D; Mitra S; Curry A; Saxena R; Bhat R; Schulz M; Diggle P
    Am J Kidney Dis; 2010 Jun; 55(6):1060-8. PubMed ID: 20207458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acid-citrate-dextrose compared with heparin in the preparation of in vivo/in vitro technetium-99m red blood cells.
    Porter WC; Dees SM; Freitas JE; Dworkin HJ
    J Nucl Med; 1983 May; 24(5):383-7. PubMed ID: 6601697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taurolidine-citrate-heparin catheter lock solution reduces staphylococcal bacteraemia rates in haemodialysis patients.
    Murray EC; Deighan C; Geddes C; Thomson PC
    QJM; 2014 Dec; 107(12):995-1000. PubMed ID: 24939191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of catheter-lock solutions on catheter-related infection and inflammatory syndrome in hemodialysis patients: heparin versus citrate 46% versus heparin/gentamicin.
    Venditto M; du Montcel ST; Robert J; Trystam D; Dighiero J; Hue D; Bessette C; Deray G; Mercadal L
    Blood Purif; 2010; 29(3):268-73. PubMed ID: 20068292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.